MedTrace Logo

Effects of Gender-affirming Hormone Therapy on Transgender People

NCT06022562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2025-08-22

No results posted yet for this study

Summary

This prospective cohort study aims to assess the impact of gender-affirming hormone therapy (GAHT) on transgender individuals' physical, psychological, social, and quality of life aspects. Based on gender minority stress theory, the research recruits 150 individuals each of those starting GAHT and those not yet undergoing it. Data collection involves questionnaires and physiological measurements. Statistical analyses will explore correlations and group differences. Findings can guide transgender individuals considering hormone therapy and enhance care guidelines to improve their overall well-being.

Conditions

  • Gender Dysphoria

Sponsors & Collaborators

  • National Taiwan University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06022562 on ClinicalTrials.gov